
Veterans Report Reduced TBI and Depression Symptoms Following Psilocybin Retreats, Study Finds
It is estimated that approximately 67% of U.S. military veterans have experienced at least one traumatic brain injury (TBI)¹. Among those deployed to Iraq or Afghanistan, an estimated 14% to 16% have been affected by PTSD or depression². For too many veterans returning from service, the invisible wounds of war persist well beyond their military service. But a new peer-reviewed study reveals that legal psilocybin retreat programs may help military veterans reduce symptoms of depression, anxiety, post-concussion syndrome, and psychological stress – offering a path that doesn’t rely solely on traditional pharmaceuticals or talk therapy. As debates around veteran mental health, psychedelic policy, and the limits of conventional care continue to gain urgency, this new research signals a meaningful path forward.Closer Look at the Study
On July 10, 2025, Brain and Behavior published a landmark study titled “Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Settings.” The research followed 58 veterans who participated in legal psilocybin and ayahuasca retreats hosted by Beckley Retreats and Synthesis Institute. The findings are among the most comprehensive to date examining the long-term effects of psychedelics outside of clinical trial settings. The participants, most of whom had been previously diagnosed with PTSD, depression, anxiety, or traumatic brain injury (TBI), were assessed at three points: before the retreat, immediately after, and again three months later. All retreats combined psychedelic sessions with therapeutic preparation and integration, group processing, and trauma-informed support.What the Data Shows
The veterans who participated in psilocybin retreats reported statistically significant reductions in:
-
- Depression: 29.1% reduction (PHQ-9)
- PTSD: 26.1% reduction (PCL-5)
-
- Anxiety and stress
-
- Post-concussion symptoms
-
- Difficulties with reintegration into civilian life
-
- Veterans in psilocybin retreats showed greater improvements in post-concussion symptoms, depression, and civilian reintegration
- Ayahuasca participants experienced slightly greater reductions in PTSD symptoms
The Science Behind the Success
The study’s rigor adds weight to its promising findings. Senior author Dr. Robin Carhart-Harris, head of the Carhart-Harris Lab at UCSF, noted: “These findings add to the growing body of evidence suggesting that psilocybin, when used in safe and legal settings with proper support, may lead to long-lasting improvements in mental health for veterans and others with complex trauma.” The research design included comprehensive pre-screening, professional therapeutic support throughout the process, and structured integration sessions to help participants process and apply insights from their experiences. Tools and Rigor Behind the Research To ensure reliable and nuanced data, researchers used a comprehensive suite of validated instruments, including:-
- Depression, Anxiety, and Stress Scales (DASS-21)
-
- Patient Health Questionnaire (PHQ-9)
-
- State-Trait Anxiety Inventory (STAI-T)
-
- Post-Concussion Symptom Questionnaire (RPQ)
-
- Military to Civilian Questionnaire (M2C-Q)
-
- PTSD Checklist for DSM-5 (PCL-5)
-
- Quality of Life After Brain Injury (QOLIBRI)